Copper, iron and zinc in Alzheimer's disease senile plaques

Journal of the Neurological Sciences

Volumn 158, Issue 1, 1998, Pages 47-52

  Lovell, M A ^a,c   Robertson, J D ^a   Teesdale, W J ^b   Campbell, J L ^b   Markesbery, W R ^a,c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF GUELPH   (Canada)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; Copper; Iron; Micro PIXE analysis; Senile plaques; Zinc

Indexed keywords

AMYLOID BETA PROTEIN; COPPER; IRON; ZINC;

AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METAL BINDING; NEUROPIL; PRIORITY JOURNAL; SENILE PLAQUE; TISSUE DISTRIBUTION;

ALZHEIMER DISEASE; AMYGDALA; BIOTINYLATION; COPPER; HUMANS; IRON; NEUROPIL; SENILE PLAQUES; SPECTROMETRY, X-RAY EMISSION; ZINC;

EID: 0032507975     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(98)00092-6     Document Type: Article

References (69)

1. 2+ from brain tissue during activity. Nature. 308:1984;734-736.
2. Ashkenazi R., Ben-Shachar D., Youdin M.B.H. Nutritional iron and dopamine binding sites in the rat brain. Pharmacol. Biomed. Behav. 17(1):1982;43-47.
3. Atwood CS, Moir RD, Huang X, Tanzi RE, Bush AI. Cerebral zinc metabolism in Alzheimer's disease. In: Waso W, Tanzi RE, editors. Molecular mechanisms of dementia. Totowa NJ: Humana Press, 1997:225-37.
4. Backstrom J.R., Miller C.A., Tokes Z.A. Characterization of neutral proteinases from Alzheimer affected and control brain specimens: identification of calcium dependent metalloproteinases from the hippocampus. J. Neurochem. 58:1992;983-992.
5. Balazs L., Leon M. Evidence of an oxidative challenge in the Alzheimer's brain. Neurochem. Res. 19:1994;1131-1137.
6. 2 receptor modulation by brain non-haem iron. Br J Pharmacol. 90:1987;2P.
7. Bush A.I., Multhaup G., Moir R.D.et al. A novel zinc (II) binding site modulates the function of the βA4 amyloid protein precursor of Alzheimer's disease. J. Biol. Chem. 268:1993;16109-16112.
8. Bush A.I., Pettingell W.H., Multhaup G.et al. Rapid induction of Alzheimer Aβ amyloid formation by zinc. Science. 265:1994;1464-1467.
9. Bush A.I., Pettingell W.H., de Paradis M., Tanzi R.E., Wasco W. The amyloid β-protein precursor and its mammalian homologues. Evidence for a zinc-modulated heparin-binding superfamily. J. Biol. Chem. 269:1994;26618-26621.
10. Bush A.I., Moir R.D., Rosenkranz K.M., Tanzi R.E. Zinc and Alzheimer's disease. Science. 268:1995;1921-1923.
11. Candy JM, Edwardson JA, Klinowski J, Oakley AE, Perry EK, Perry RH. Colocalization of aluminum and silicon in senile plaques: Implications for the neurochemical pathology of Alzheimer's disease. In: Traver J, Gispen GH, editors. Senile dementia of the Alzheimer's type. Berlin: Springer-Verlag, 1985:185-97.
12. Candy J.A., Oakley A.E., Klinowski J.et al. Aluminosilicates and senile plaque formation in Alzheimer's disease. Lancet. 1(8477):1986;354-357.
13. Connor J.R., Menzies S.L., St. Martin S.M., Mufson E.J. A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J Neurosci Res. 31:1992;75-83.
14. Connor J.R., Menzies S.L. Cellular management of iron in the brain. J Neurol Sci. 134(Suppl.):1995;33-44.
15. Connor J.R., Snyder B.S., Beard J.L., Fine R.E., Mufson E.J. Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease. J Neurosci Res. 31:1992;327-335.
16. Corrigan F.M., Reynolds G.P., Ward N.I. Hippocampal tin, aluminum and zinc in Alzheimer's disease. Biometals. 6:1993;149-154.
17. Crapper D.R., Krishnan S.S., Patton A.J. Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration. Science. 180:1973;511-513.
18. Crapper D.R., Krishnan S.S., Quittkat S. Aluminum, neurofibrillary degeneration and Alzheimer's disease. Brain. 99:1976;67-80.
19. Diebel M.A., Ehmann W.D., Markesbery W.R. Copper, iron and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. J. Neurol. Sci. 143:1996;137-142.
20. Ehmann W.D., Markesbery W.R., Alauddin M., Hossain T.I.M., Brubaker E.H. Brain trace elements in Alzheimer's disease. Neurotoxicology. 7:1986;197-206.
21. el Lozy M, Herreva MG, Latham MC, McGrady RB, McCann MB, Stare FJ. Nutrients. In: Nutrition. Kalamazoo MI: Upjohn, 1980:51-85.
22. Evans D.A., Funkenstein H.H., Albert M.S.et al. Prevalence of Alzheimer's disease in a community population of older persons. JAMA. 262:1989;2551-2556.
23. Good P.F., Perl D.P., Bierer L.M., Schmeidler J. Selective accumulation of aluminum and iron in neurofibrillary tangles of Alzheimer's disease: A laser microprobe (LAMMA) study. Ann. Neurol. 31:1992;286-292.
24. Goodman L. Alzheimer's disease: A clinico-pathologic analysis of twenty-three cases with a theory on pathogenesis. J. Nerv. Ment. Dis. 117(2):1953;97-130.
25. Grundke-Iqbal I., Fleming J., Tung Y.C., Lassman H., Iqbal K., Joshi J.G. Ferritin is a component of neuritic (senile) plaques in Alzheimer dementia. Acta Neuropathol. 81:1990;105-110.
26. Halliwell B. Oxygen radicals as key mediators in neurological disease: Fact or fiction? Ann. Neurol. 32(suppl):1992;S10-S15.
27. Harman D. Free radical theory of aging: A hypothesis on pathogenesis of senile dementia of the Alzheimer's type. Age. 16:1993;23-30.
28. Hensley K., Carney J.M., Mattson M.P.et al. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevence to Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 91:1994;3270-3274.
29. Hensley K., Hall N., Subramaniam R.et al. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65:1995;2146-2156.
30. Hershey C.O., Hershey L.A., Varnes A., Vibhaker S.D., Levine P., Strain W.H. Cerebrospinal fluid trace element content in dementia: clinical, radiologic and pathologic correlations. Neurology. 33:1983;1350-1353.
31. Hess K., Straub P.W. Chronische Bleivergiftung. Praxis. 63:1974;177-183.
32. Howell G.A., Welch M.G., Frederickson C.J. Stimulation-induced uptake and release of zinc in hippocampal slices. Nature. 308:1984;736-738.
33. Johansson SAE, Campbell JL. PIXE: A novel technique for elemental analysis. New York: John Wiley and Sons, 1988.
34. Khachaturian Z.S. Diagnosis of Alzheimer's disease. Arch. Neurol. 42:1985;1097-1105.
35. Kemp K., Danscher G. Multi-element analysis of the rat hippocampus by proton induced X-ray emission spectroscopy (phosphorus, sulphur, chlorine, potassium, calcium, iron, zinc, copper, lead, bromine, and rubidium). Histochemistry. 59:1979;167-176.
36. Kromer-Vogt L.J., Hyman B.T., Van Hoesen G.W., Danasio A.R. Pathologic alterations in the amygdala in Alzheimer's disease. Neuroscience. 37:1990;377-385.
37. Landsberg J.P., McDonald B., Watt F. Absence of aluminum in neuritic plaque cores in Alzheimer's disease. Nature. 360:1992;65-68.
38. Landsberg J.P., McDonald B., Grime G., Watt F. Microanalysis of senile plaques using nuclear microscopy. J Geriatr. Psychiatry Neurol. 6:1993;97-104.
39. Levy-Lahad E., Bird T.D. Genetic factors in Alzheimer's disease: A review of recent advances. Ann. Neurol. 40:1996;829-840.
40. Lovell M.A., Robertson J.D., Ehmann W.D., Markesbery W.R., Teesdale W.J., Campbell J.L. Comparison of laser microprobe mass spectrometry (LMMS) and micro particle induced X-ray emission (micro-PIXE) for the analysis of senile plaques in AD: a preliminary study. J. Radioanal. Nucl. Chem. Articles. 95(1):1995;7-12.
41. Lui E., Fisman M., Wong C., Diaz F. Metals and the liver in Alzheimer's disease: an investigation of hepatic zinc, copper, cadmium and metallothionein. J. Am. Geriatr. Soc. 38:1990;633-639.
42. Markesbery WR, Ehmann WD. Brain trace elements in Alzheimer disease. In: Terry RD, Katzman R, Bick KL, editors. Alzheimer disease. New York: Raven Press, 1994:353-67.
43. Markesbery WR, Ehmann WD, Alauddin M, Hossain TIM. Brain trace element concentrations in aging. Neurobiol Aging 1984:19-28.
44. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med. 23:1997;123-137.
45. Maxwell J.A., Teesdale W.J., Campbell J.L. Compensation schemes for peak-tailing uncertainties in PIXE spectra using the GUPIX code. Nucl. Instrum. Methods Phys. Res. B94:1994;172-179.
46. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 34:1984;939-944.
47. Meccoci P., MacGarvey U., Beal M.F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36:1994;747-751.
48. Mirra S.S., Heyman A., McKeel D.et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 41:1991;479-486.
49. Moretz R.C., Iqbal K., Wisniewski H.M. Microanalysis of Alzheimer's disease NFT and plaques. Env. Geochem. Health. 12(1-2):1990;15-16.
50. Multhaup G., Schlicksupp A., Hesse L.et al. The amyloid precursor protein of Alzheimer's disease in the reduction of copper (II) to copper (I). Science. 271:1996;1406-1409.
51. Nikaido T., Austin J., Trueb L., Rinehart R. Studies in aging of the brain. Arch. Neurol. 27:1972;549-554.
52. Nitsch R.N., Blusztajn J.K., Pittas A.G., Slack B.E., Growdon J.H., Wurtman R.J. Evidence for a membrane defect in Alzheimer's disease brain. Proc. Natl. Acad. Sci. USA. 89:1992;1671-1675.
53. Perl D.P., Brody A.R. Alzheimer's disease: X-ray spectometric evidence of aluminum accumulation in neurofibrillary tangle bearing neurons. Science. 208:1980;297-299.
54. Plantin L.-O., Lysing-Tunell U., Kristensson K. Trace elements in the human central nervous system studied with neutron activation analysis. Biol. Trace Elem. Res. 13:1987;69-75.
55. Sahu R.N., Pander R.S., Subhash M.W., Arya B.Y.T., Pedmashree T.S., Srinivas K.N. CSF zinc in Alzheimer's type dementia. Biol. Psychiatry. 24:1988;480-482.
56. Samudralwar D.L., Diprete C.C., Ni B.-F., Ehmann W.D., Markesbery W.R. Elemental imbalances in the olfactory pathway in Alzheimer's disease. J. Neurol. Sci. 130:1995;139-145.
57. Smith C.D., Carney J.M., Starke-Reed P.E.et al. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer's disease. Proc. Natl. Acad Sci USA. 81:1991;10540-10543.
58. Switzer RC, Martin TL, Campbell SK, Parker JC, Caldwell ED. Iron and ferritin in the neuritic plaques of Alzheimer's disease. Soc Neurosci Abstr 1986;100.
59. Tandon L., Ni B.-F., Ding X.X., Ehmann W.D., Kasarskis E.J., Markesbery W.R. RNAA for arsenic, cadmium, copper, and molybdenum in CNS tissues from subjects with age-related neurodegenerative diseases. J Radioanal Nucl Chem. 179:1994;331-339.
60. Thompson C.M., Markesbery W.R., Ehmann W.D., Mao Y.X., Vance D.E. Regional brain trace element studies in Alzheimer's disease. Neurotoxicology. 9:1988;1-8.
61. Tonder N., Johansen F.F., Frederickson C.J., Zimmer J., Diemer N.H. Possible role of zinc in the selective degeneration of dentate hilar neurons after cerebral ischemia in the adult rat. Neurosci. Lett. 109:1990;247-252.
62. Trapp G.A., Miner G.D., Zimmerman R.L., Mastri A.R., Heston L.L. Aluminum levels in brain in Alzheimer's disease. Biol. Psychiatry. 13:1978;709-718.
63. Uchida Y., Takio K., Titani K., Ihara Y., Tomonaga M. The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein. Neuron. 7:1991;337-347.
64. Ward N.I., Mason J.A. Neutron activation analysis techniques for identifying elemental status in Alzheimer's disease. J. Radioanal. Nucl. Chem. 113:1987;515-526.
65. Wenstrup D., Ehmann W.D., Markesbery W.R. Trace element imbalances in isolated subcellular fractions of Alzheimer's disease brains. Brain Res. 533:1990;125-131.
66. Wilmore L.J., Sypert G.W., Manson J.V., Hurd R.W. Chronic focal epileptiform discharges induced by injection of iron into rat and cat cortex. Science. 200:1978;1501-1503.
67. Xu N., Majidi V., Ehmann W.D., Markesbery W.R. Determination of aluminum in human brain tissue by electrochemical atomic absorption spectrometry. J. Anal. At. Spectrom. 7:1992;749-751.
68. Yoshimasu F., Masyuki M., Yoshiro Y.et al. Studies on amyotrophic lateral sclerosis by neutron activation analysis: 2. Comparative study of analytical results on Guam PD, Japanese ALS and Alzheimer disease cases. Folia Psychiatr. Neurol. Jpn. 34:1980;75-82.
69. Youdim M.B.H., Ben-Shachar D. Minimal brain damage induced by early iron deficiency: modified dopaminergic neurotransmission. Isr. J. Med. Sci. 23:1987;19-25.